Jazz Pharmaceuticals
JAZZ
JAZZ
446 hedge funds and large institutions have $7.76B invested in Jazz Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 163 increasing their positions, 132 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
446
Holders Change
+41
Holders Change %
+10.12%
% of All Funds
8.81%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
89
Increased
163
Reduced
132
Closed
34
Calls
$33.9M
Puts
$40M
Net Calls
-$6.13M
Net Calls Change
-$11.6M
Top Buyers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$104M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$94.2M |
| 3 |
Renaissance Technologies
New York
|
+$64.4M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$44.9M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$37.6M |
Top Sellers
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$76.4M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$74.1M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$67.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$65.4M |
| 5 |
JPMorgan Chase & Co
New York
|
-$38.1M |
